2021
DOI: 10.1007/s10529-021-03180-4
|View full text |Cite
|
Sign up to set email alerts
|

A critical appraisal of humanized alternatives to fetal bovine serum for clinical applications of umbilical cord derived mesenchymal stromal cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 64 publications
0
2
0
Order By: Relevance
“…Currently, autologous blood plasma could be considered a 'gold standard' for cell cryopreservation in clinical practice, which has been well studied since the 1990s (57,58). Human cord blood plasma has also recently been described among the novel alternative FBS compounds for MSC culture (59)(60)(61)(62).…”
Section: Xeno-contamination Reactions Caused By Components Of Culture...mentioning
confidence: 99%
“…Currently, autologous blood plasma could be considered a 'gold standard' for cell cryopreservation in clinical practice, which has been well studied since the 1990s (57,58). Human cord blood plasma has also recently been described among the novel alternative FBS compounds for MSC culture (59)(60)(61)(62).…”
Section: Xeno-contamination Reactions Caused By Components Of Culture...mentioning
confidence: 99%
“…STRO-1 has been observed in multipotent mesenchymal cells, and it is a promising marker of mesenchymal stem cells in regenerative medicine, owing to their multipotent characteristics and self-renewal effects. [23][24][25] We hypothesized that the upregulation of STRO-1 expression indicates the regeneration process in the dermis; however, extensive research is necessary to confirm this hypothesis.…”
Section: Ta B L Ementioning
confidence: 99%
“…A detailed discussion of the in vitro uses and in vivo therapeutic applications of these novel CB components is outside the scope of this article. The interested reader can find the encouraging, preliminary evidences so far reported in several reviews (Petrini, 2012;Querol and Samarkanova, 2019;Rebulla et al, 2019;Samarkanova et al, 2020a) and laboratory studies (Parazzi et al, 2010;Cox et al, 2015;Parazzi et al, 2015;Ferri et al, 2016;Longo et al, 2016;Rebulla et al, 2016;Shirzad et al, 2017;Stokhuijzen et al, 2017;Christou et al, 2018;Cox et al, 2018;Valentini et al, 2019;Samarkanova et al, 2020b;Rallapalli et al, 2021). A selection of published investigations on the clinical use of CB platelets, plasma and red blood cells in wound healing, ophthalmology, neonatal and pediatric transfusion is reported in Table 1.…”
Section: Introductionmentioning
confidence: 99%